Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft S

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced a strategic partnership agreement with CGBio, a developer of innovative, synthetic bone grafts currently used clinically in Asia for spine, orthopedic, trauma a...

Related Keywords

Mexico ,Australia ,United States ,India ,Texas ,Canada ,South Korea ,Lewisville ,Canadian ,American ,Jon Serbousek ,Los Angeles ,Jeffrey Wang ,Denise Landry ,Alexa Huerta ,Hyun Seun Yu ,Daewoong Pharmaceuticals ,University Of Southern California ,Nasdaq ,Keck Medical Center ,Spine Center ,Securities Exchange ,Orthofix Medical Inc ,American Association Of Tissue Banks ,Orthofix Medical ,Orthofix President ,Orthopaedic Surgery ,Southern California ,Southeast Asia ,American Association ,Tissue Banks ,Securities Exchange Act ,Securities Act ,Risk Factors ,Annual Report ,